What we measure is a choice, which reflects implicitly our value system--Measuring What Counts The Global Movement for Well-Being
I haven't been writing consistently about Alzheimer's disease lately because to be honest, it often feels like shouting into a black hole.
Gina Kolata from the New York Times writes, "But the studies of anti-amyloid drugs completed so far have repeatedly failed. Companies have spent billions of dollars on the drugs. Some, like Pfizer, have gotten out of the race altogether.
Many researchers say they are not yet ready to give up.
The disease, they note, always progresses in the same way: Amyloid accumulates in the brain and then a tangled, spaghetti-like protein, tau, appears and neurons die."-- An Alzheimer's Treatment Fails: "We Don't Have Anything Now"